Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
Project ACCESS: Advancing Access to HIV/HCV Testing Through Transformation in Syringe Services Programs: A Cluster Randomized Trial
University of Miami
40 participants
Jun 27, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).
Eligibility
Inclusion Criteria6
- SSPs must:
- be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions;
- serve at least 300 unique participants per year;
- not currently offer opt-out HIV/HCV testing;
- be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics;
- have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.
Exclusion Criteria4
- SSPs must not:
- currently receive or have received Frontline Communities in the United States (FOCUS) funding;
- have already implemented opt-out HIV/HCV testing.
- currently participating in SAIA-SSP-HIV (NCT06025435)
Interventions
Participants will receive the ACCESS intervention with funding, consisting of up to 16 hours of practice facilitation per month in person and/or virtually. Practice facilitation is training and support on implementation of routine HIV/HCV screening.
Participants will receive a link to the CDC compendium of evidence-based interventions for HIV prevention.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06730555